Eda H, Tanaka Y, Ishitsuka H
Nippon Roche Research Center, Dept. of Oncology and Immunology, Kanagawa, Japan.
Cancer Chemother Pharmacol. 1991;29(1):1-6. doi: 10.1007/BF00686327.
The cytostatic agent 5'-deoxy-5-fluorouridine (5'-dFUrd) improves cachexia and prolongs survival, suppressing tumor growth in mice bearing large burdens of colon 26 adenocarcinoma. To investigate the mode of this anticachectic action, we isolated colon 26 variants that were resistant to the anticachectic activity in vivo in tumor-bearing mice that initially responded to 5'-dFUrd in terms of tumor growth and cachexia but again became cachectic and refractory to the drug after prolonged treatment. The original line and variants were equally susceptible to the antiproliferative action of 5'-dFUrd, and their growth was stopped. However, 5'-dFUrd given to cachectic mice exhibiting large burdens of these variants could not reverse wasting and only slightly prolonged the survival period. These results indicate that the anticachectic activity of 5'-dFUrd is independent of its antiproliferative action and that the survival of colon 26-bearing mice is shorter when the size of the tumors is not reduced to levels below those that cause cachexia.
细胞生长抑制剂5'-脱氧-5-氟尿苷(5'-dFUrd)可改善恶病质并延长生存期,抑制携带大量结肠26腺癌的小鼠的肿瘤生长。为了研究这种抗恶病质作用的模式,我们分离出了对荷瘤小鼠体内抗恶病质活性具有抗性的结肠26变体,这些小鼠最初在肿瘤生长和恶病质方面对5'-dFUrd有反应,但在长期治疗后再次出现恶病质且对该药物产生耐药性。原始细胞系和变体对5'-dFUrd的抗增殖作用同样敏感,它们的生长被抑制。然而,给予表现出大量这些变体的恶病质小鼠5'-dFUrd并不能逆转消瘦,仅略微延长了生存期。这些结果表明,5'-dFUrd的抗恶病质活性与其抗增殖作用无关,并且当携带结肠26肿瘤的小鼠的肿瘤大小未减小到引起恶病质的水平以下时,其生存期会更短。